COVID-19 vaccines and kidney disease

Nat Rev Nephrol. 2021 May;17(5):291-293. doi: 10.1038/s41581-021-00406-6. Epub 2021 Feb 8.

Abstract

Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Humans
  • Immunosuppression
  • Kidney Diseases / complications
  • Kidney Diseases / immunology*
  • Renal Dialysis
  • SARS-CoV-2 / immunology*
  • Vaccination

Substances

  • COVID-19 Vaccines